Vascudyne Announces Successful First Human Use of TRUE Vascular Graft for Hemodialysis Access View more
Pear Therapeutics and Serve You Rs Announce Formulary Coverage for Prescription Digital Therapeutic Somryst and People With Chronic Insomnia View more
Pear Therapeutics Announces First Participant Enrolled in National Institutes of Health Clinical Trial Investigating Combinations of Pharmacological and Behavioral Interventions to Treat Opioid Use Disorder View more
